STERIS’ (TSE:STE – Free Report) – Equities research analysts at Cormark lowered their FY2025 EPS estimates for STERIS’ in a research note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now forecasts that the company will post earnings per share of $0.94 for the year, down from their previous forecast of $1.02.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, topping the consensus estimate of C$0.12 by C$0.02. The firm had revenue of C$231.38 million for the quarter, compared to analyst estimates of C$226.20 million.
STERIS’ Stock Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- Why is the Ex-Dividend Date Significant to Investors?
- What a Trump Win Looks Like for the Market Now and Into 2025
- 3 Stocks to Consider Buying in October
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
